(1 - 5 von 6
)
Galmed Pharma (NASDAQ:GLMD) - Galmed Pharma Reports Expansion of...
www.benzinga.com
Dr. Evelyn Darius will serve as the Study Investigator. If the PK profile from Part A is similar to the existing PK data in non-Chinese subjects, ...
Galmed expands ongoing Phase IIb ARREST study to China GLMD - The Fly
thefly.com
Galmed …s an... GLMD
History of Changes for Study: NCT
clinicaltrials.gov
Contact:Principal Investigator: Evelyn Darius. United States, Ohio. Medpace CPU [Recruiting] Cincinnati, Ohio, United States, › history
sortiert nach Relevanz / Datum